Delivery Order SPE2DR25D2208-SPE2DR26FB4QM
Award Date 11/26/25
Potential Completion Date 11/28/25
Potential Value $1.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $4,314.56 to supply Repaglinide 1 mg tablets (90-count units) with a completion date of December 2, 2025. This firm fixed-price contract, awarded without set-aside designation on December 1, 2025, will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a competitive procurement for pharmaceutical products supporting federal medical supply needs. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Repaglinide 1 mg tablets in a 90-count package at a firm fixed price of $1,189.32. This is a non-set-aside, competitively awarded contract with an ultimate completion date of December 4, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order as a child contract under its larger Indefinite...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Repaglinide 1 mg tablets in quantities of 100 units. This competitively awarded, non-set-aside contract carries a ceiling value of $4,911.34 with firm fixed pricing and an ultimate completion date of July 15, 2025. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order falls under...
- This federal contract award is for the delivery of Repaglinide 1 mg tablets to the Defense Logistics Agency (DLA). The fixed-price delivery order, valued at $7,964.57, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of March 1, 2024 and is not designated as a set-aside. AmerisourceBergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which holds significant Indefinite...
- This federal contract award, with ID SPE2DB20D3103|SPE2DB25FN5D9, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,567,983,951 units of the medication Repaglinide 1 mg Tablet in 100-count packages, with a ceiling value of $3,113.50. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 22, 2025. The contract is not set aside and was awarded on April 21,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $6,798.50, is for the delivery of 4,563,575,086 units of the pharmaceutical product Repaglinide 1 mg Tablet in 100-count packages. The contract is a Firm Fixed Price Delivery Order with a completion date of February 7, 2024. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major...
- The Defense Logistics Agency awarded a $194,050 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100-count bottles of 2 mg Repaglinide tablets. The prime contractor will deliver the generic diabetes medication to a facility in Conshohocken, Pennsylvania by August 17, 2023 in support of the Department of Defense pharmacy programs. No subcontractors or set aside designations were identified. The order was placed under an existing DLA pharmaceutical supply vehicle and...
- This delivery order for $323 is for 100 tablets of 2 mg repaglinide, awarded by the Defense Logistics Agency Troop Support Medical to Amerisourcebergen Drug Corp. The contract has no set-aside designation and performance will occur in Conshohocken, Pennsylvania by October 2023. Amerisourcebergen Drug Corp is a division of Amerisourcebergen Corporation, which will serve as the prime contractor for this firm fixed price order to supply diabetes medication in support of the Defense Logistics...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Repaglinide 1 mg tablets, a medication used to manage diabetes, with a ceiling value of $13,095.99 and a period of performance through May 6, 2024. The contract was awarded as a Firm Fixed Price Delivery Order and was not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award, identified as SPE2DB24D1034|SPE2DB25FWAQ2, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567321287 units of 1 mg Repaglinide tablets, a medication used to treat type 2 diabetes. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,628.82 and a period of performance through February 21, 2025. This award...